Monte Rosa Therapeutics Inc
GLUEHealthcare|Biotechnology|USA
$23.02
-1.48 (-6.04%)
Tangible Book
$6.19
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Awaiting Results (2)
Trials past primary completion date but still active — data readout may be imminent.
Jul 2026
P1
A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
NCT07119125